Abstract: Retinoids, the active metabolites of vitamin A, regulate complex gene networks involved in vertebrate morphogenesis, growth, cellular differentiation, and homeostasis. They are used for the treatment of skin disorders and as chemopreventive agents for certain cancers. Molecular biology and genetic studies performed during the last 15 years in vitro, using either acellular systems or transfected cells, have shown that retinoid actions are mediated through heterodimers between the 8 major RARα, β, and γ isoforms and the 6 major RXRα, β, and γ isoforms that belong to the nuclear receptor (NR) superfamily, and act as ligand-dependent transcriptional regulators. Furthermore, RXRs not only heterodimerize with RARs, but also with numerous other members of the NR superfamily. As in vitro studies are carried out under nonphysiological conditions, they only indicate what is possible, but not necessarily what is actually occurring in vivo. Therefore, mutations have been introduced by homologous recombination (HR) in F9 embryonal carcinoma (EC) cells, a cell-autonomous system that differentiates in the presence of RA, in order to disrupt RAR and RXR genes and establish their cellular and molecular functions in RA-induced differentiation. However, genetic approaches in the animal should be used to determine the function of retinoid receptors under truly physiological conditions. HR in embryonic stem (ES) cells, has therefore been used to generate null mutations of the various RARs and RXRs in the mouse germline. As reviewed here, the generation of such RAR and RXR germline mutations, combined with pharmacological approaches to block the RA signaling pathway, has provided many valuable insights on the developmental functions of RA receptors. However, due to (i) the complexity in "hormonal" signaling through transduction by the multiple RARs and RXRs, (ii) the functional redundancies (possibly artefactually generated by the mutations) within receptor isotypes belonging to a given gene family, and (iii) in utero or postnatal lethality of certain germline null mutations, these genetic studies through germline mutagenesis have failed to reveal many of the physiological functions of RARs and RXRs, notably in adults. We conclude that spatiotemporally controlled somatic mutations generated in animal models in given cell-types/tissues and at chosen times during pre-and postnatal life, are required to reveal the physiological and pathophysiological functions of the receptor genes involved in the retinoid signaling pathway throughout the life of the mouse.
GENETIC EVIDENCE THAT RARs TRANSDUCE RETINOID SIGNALS IN VIVO: RAR (a, b, AND c) NULL MUTANT MICE DISPLAY SEVERAL ASPECTS OF THE POSTNATAL VAD SYNDROME AS WELL AS SOME CONGENITAL ABNORMALITIES

RARα inactivation results in a spermatogenetic impairment and reappearance of an atavistic trait
While RARα1 and RARα2 null mutants are apparently normal, RARα null mutants males are sterile due to a low production of spermatozoa [27, 28 , and our unpublished results] ( Table 1 ). The Sertoli cell is the main target of the RARα null mutation, as the RARα protein is normally readily detectable in these cells, but not in germ cells [28, 29] . Spermatogenesis is complete in adult mutants testes, which nevertheless display a degeneration characterized by the presence of large and empty vacuoles located between Sertoli cells. These vacuoles probably appear as a consequence of a chronic loss of round spermatids, which are prematurely released into the lumen of the mutant seminiferous tubules, before the completion of their maturation phase (spermiogenesis). The nature of the seminiferous epithelium lesions suggests that a signaling pathway mediated by RARα favors cell cohesiveness within the seminiferous epithelium. Interestingly, a RA-inducible gene, Stra6, encodes an integral membrane protein of Sertoli cells whose spermatogenetic cycle-dependent expression is lost in testes of RARα null mutants [30] . The onset of the testicular degeneration is variable: in some RARα null testes, numerous vacuoles are already present at P10 [postnatal day 10, i.e., before completion of puberty (around P35)], whereas other mutant testes still appear histologically normal at six weeks of age (our unpublished results). A second intriguing feature of adult RARα null testes is the patchy distribution of the lesions: seminiferous tubules containing a full complement of germ cells are often found adjacent to tubules composed almost exclusively of Sertoli cells [28] . This variability suggests that RARβ and RARγ, which are also detected in Sertoli cells [31, 32] , partially compensates for the lack of RARα, and that their activity varies stochastically among RARα null mutant males, and also between the seminiferous tubules of a given RARα null testis. Functional compensation by RARβ and RARγ probably also accounts for the observation that the RARα null testicular phenotype mimics a state of mild VAD, as opposed to a severe and prolonged VAD, which yields testes devoid of germ cells [33] .
Aside from this completely penetrant testis degeneration, some RARα null mutants show some congenital defects (Table 1) , which include interdigital webbing and a supernumerary skeletal element connecting the incus (a middle ear ossicle) with the alisphenoid bone (a braincase bone). This latter congenital abnormality corresponds to an atavistic trait, defined as the reappearance of a character that was lost during evolution, namely the upper jaw (or pterygoquadrate) cartilage present in reptilian ancestors of mammals. The occurrence of several other atavistic features in RAR single and double null mutants strongly support the view that modulation of RA signaling has been employed during vertebrate evolution as a mean to modify skull shapes and functions (see refs. [34] [35] [36] [37] ).
RARγ inactivation causes epithelial defects and some congenital malformations
RARγ males are sterile but, contrary to RARα null mice, their spermatogenesis is normal [38] (Table 1) . This sterility results from the transformation of the glandular epithelia of the seminal vesicle and prostate (which normally produce essential fractions of the seminal fluid) into epithelia resembling epidermis. Aside from sterility, this aberrant cell differentiation process known as "squamous metaplasia" is responsible for severe genito-urinary tract infections, and extends, upon aging, to other epithelia, namely those of the epididymis, urinary bladder, urethra, and salivary glands [33] . As squamous metaplasia is one of the hallmarks of the postnatal VAD syndrome (see Introduction), RARγ probably plays a crucial role in the maintenance of all epithelia that require RA in the mouse. Along these lines, it is noteworthy that keratinization of the tracheal and conjunctival epithelia, which are hallmarks of rat VAD, are not seen in models of VAD mice, such as CRBPI (cellular retinol binding protein one) and RBP (retinol binding protein) null mutants raised on VAD diets, possibly reflecting species-specific differences in RA tissue requirements [33, and our unpublished results] . Likewise, RARγ null mice and VAD mice, surprisingly, do not develop the corneal ulcerations found in the human VAD [39] . 
-/-, and RARγ2 -/-refer to isoform-specific knock-outs.
RARγ null newborns are readily distinguishable from their littermates by the glossy appearance of their skin [40] . Their flat epidermal surface, accounting for this characteristic external aspect, likely reflects a deficit in corneodesmosomes which normally provide cell cohesion within the stratum corneum. Moreover, lamellar bodies in the mutant epidermal granular layer are morphologically abnormal and fail to be properly exocytosed, resulting in an accumulation of abnormal vesicles in extracellular spaces and uneven deposition of lipids in the stratum corneum (our unpublished results). These defects persist in adults, and are reminiscent of those observed in cases of human congenital ichthyoses and in elderly skin xerosis. RA is a widely used therapeutic agent for skin diseases. In this context, it is noteworthy that the subtle role of RARγ in the differentiation of granular keratinocytes, which is revealed only by careful electron microscopic analysis of the RARγ null mutants, probably represents the only physiological functions of the whole RAR family in the homeostasis of the mouse resting epidermis [41] .
RARγ null newborns also display laryngeal and tracheal cartilage malformations, as well as interdigital webbing (Table 1 ). The Harderian glands, which provide for lubrification of the eyelids are often missing in RARγ null mutants. Moreover, all of these mutants (as well as some RARα and RARβ mutants) display homeotic transformations of cervical vertebrae, indicating that signaling through RARs is required for the patterning of the antero-posterior body axis during somite formation [35, 38] (Table 1) .
Interestingly, mice lacking specifically the RARγ1 isoform display the congenital skin defect, as well as vertebral and laryngeal malformations characteristic of the RARγ null mutation (all isoforms disrupted), but not the squamous metaplasia, interdigital webbing, and Harderian gland agenesis of RARγ null mutants [38, 42] . In contrast, RARγ2 null mutants are apparently normal [38, 42] (Table 1) . Thus, RARγ1 is the main RARγ isoform involved in several developmental processes, postnatal growth and skin homeostasis, whereas any of the two isoforms can perform the RARγ functions required for the maintenance of genito-urinary tract and glandular epithelia, and for the involution of the interdigital mesenchyme .
RARβ null mutants display the most frequent congenital VAD abnormality and a locomotor deficiency
Almost all RARβ null mutants display a persistent hyperplastic primary vitreous body (PHPV or retrolenticular membrane), consisting in an abnormal mass of fibro-vascular tissue which is interposed between the lens and the retina, and representing the most frequent malformation of the fetal VAD syndrome [8, 35] (Table 1) . The RARβ null mutants PHPV can be ascribed to a lack of RARβ2/β4 isoform activity, as it is also observed in almost all RARβ2/β4 null mutants [43] . In contrast, specific inactivations of RARβ1 and RARβ1/β3 isoforms do not yield morphological defects [44] .
Abundant RARβ protein is detected in the adult central nervous system, notably in the striatum which is involved in the control of voluntary movements. Despite the apparent normality of this structure at the morphological level, all RARβ mutants display severely impaired abilities in locomotion and motor coordination tests [45] . Performance deficits in spatial learning, possibly unrelated to the visual impairment caused by the PHPV, and alterations of hippocampal synaptic plasticity have also been reported in RARβ null mutants [46] .
SIGNALING THROUGH RARs IS INDISPENSIBLE, AT MANY DISTINCT DEVELOPMENTAL STEPS, FOR EMBRYONIC PATTERNING AND SHAPING, AND ORGANOGENESIS
As reviewed above, RARα, RARβ, and RARγ null mutant mice altogether display some aspects of the postnatal and fetal VAD syndromes (Table 1) . However, RAR (α, β, or γ) single null mutant mice abnormalities are confined to a small subset of the tissues normally expressing these receptors during embryogenesis and adulthood, probably reflecting the existence of functional redundancies between RARs [discussed in 3, 22, 47, 48] . To test this hypothesis, mutants lacking a pair of RAR isotypes (RARαβ, RARαγ and RARβγ double null mutants) or two or more isoforms belonging to distinct isotypes were generated. For the sake of clarity, only abnormalities displayed by double null mutants lacking a cou- Tables 2 and 3 . Similar abnormalities, albeit often less penetrant, which are displayed by "isoform-specific" double null mutants are listed in [3] (RARα1/RARβ2/4, RARα1/RARγ, RARα1α2 +/-/RARγ and RARβ2/4/RARγ mutants), in [42] (RARα/RARγ1 and RARα/RARγ2 mutants), in [49] (RARα1/RARβ mutants), [44] (RARα/RARβ1/3 and RARβ1/3/RARγ mutants), and in [43] (RARβ2/RARγ2 mutants). This abnormality is completely penetrant. NA not applicable as the corresponding structure is normally not found at E14.5, the time around which RXRα null mutants die. From refs. [24, 34, 35] . Note that most of the abnormalities seen in RARα/RARβ double null mutants occur at similar frequencies in RARα/RARβ2 mutants [50] . RARαβ, RARαγ and RARβγ double null mutants, as well as double mutants for RAR isoforms belonging to different isotypes (with the exception of RARβ2/RARγ2) die in utero or at birth because of severe developmental defects that altogether include the complete spectrum of malformations corresponding to the classical fetal VAD-induced syndrome reported by Warkany's group 50 years ago [8] ( Table 2) . As RAR single mutants (see Table 1 and above), RAR double null mutants (Table 3 ) also exhibit congenital abnormalities that were not described in the classical fetal VAD studies, ranging from ageneses of the Harderian glands to skeletal defects of the skull, face, vertebrae and limbs [34, 35, 38, 42, 49, 50] . The occurrence of these "non-VAD" defects in RAR double null mutant mice is most probably accounted by the difficulty to achieve, by dietary deprivation, a state of profound VAD compatible with pregnancy (see above). In fact, almost all these "non-VAD" defects have been subsequently produced in rodent embryos (i) deficient in vitamin A, but supplemented with RA [11, 12, 51] ; (ii) lacking the RA synthesising enzymes RALDH2 (retinaldehyde dehydrogenase 2) or RALDH3 [52-56; and our unpublished results] or (iii) treated with synthetic retinoids possessing panRAR antagonistic activities [57] [58] [59] .
The comparison of the RAR double null mutants phenotypes with those of rodents carrying the aforementioned blocks in RA signal transduction, demonstrate that liganded RARs play crucial roles at M. MARK AND P. CHAMBON many distinct stages of the development of numerous organs [3, and refs. therein] . For example, the severe malformations found in RARαγ double null embryos are similar to those of RALDH2 null embryos, and reflect early roles of RAR signaling in axial rotation, mesoderm segmentation and closure of the hindbrain, formation of otocysts, pharyngeal arches, and forelimb buds, as well as in closure of the primitive gut [58] . RARs are also indispensable for the ontogenesis of (almost) all the anatomical structures that are derived from mesectodermal cells, i.e., the cranial neural crest cells (NCCs) that give rise to mesenchymal derivatives (reviewed in refs. [3, 36, 37] , and see below). RARs are involved in antero-posterior patterning of the somitic mesoderm and hindbrain neurectoderm [34, 35, 38, 58, 60] through controlling homeobox gene expression [60] [61] [62] [63] , as well as in the establishment of the anteroposterior axis of the limbs [22, 34, 64] . RARs are required for the development of a large number of eye structures (Tables 2 and 3 ) and for retinal histogenesis [34, 35, 43] , cardiomyocyte differentiation [24, 65] , as well as for the control of apotosis in the retina [43] , the frontonasal and interdigital mesenchymes [34, 35, 64] , and conotruncal segment of the embryonic heart [44] . In the embryonic urogenital tract, RARs control epithelial-mesenchymal interactions in the kidney through expression of the receptor tyrosine kinase Ret [66] [67] [68] , as well as the formation of the genital ducts and ureters [35, 50, 68] . RARs also regulate distinct steps of lung morphogenesis and are required for the partitioning of the primitive foregut into oesophagus and trachea [69, and see below] .
Due to the apparent functional redundancy between RARs in RAR knocked-out mice (discussed in refs. [3, 22, 47, 48] ), the number of organs that require RA for their development might be underestimated from the panel of malformations displayed by RARαβ, RARαγ, and RARβγ isotype or isoform double mutants (Tables 2 and 3 ). In this respect, it is noteworthy that the developing tooth, one of the favorite models for the study of morphogenetic epithelial-mesenchymal interactions, expresses a specific RA-metabolizing enzyme (P. Dollé, personal communication) and critically requires RA in organ cultures [70, 71] , although it is not obviously altered in any of the RAR double null embryos.
RXRa IS ESSENTIAL FOR TRANSDUCING RA SIGNALS NECESSARY FOR THE DEVELOPMENT OF THE MYOCARDIUM AND EYE STRUCTURES
All RXRα null mutants display an hypoplasia of the compact layer of the ventricular myocardium manifested on histological sections by thin and spongy ventricular walls. This defect appears to be the main cause of mutant death, occurring by cardiac failure around E14.5 [24, 65, 72] (Table 2) . A similar hypoplasia of the myocardium is observed in VAD fetuses, and in some RAR double null fetuses [8, 50] , suggesting that RXRα is involved in the transduction of an RA signal required for myocardial growth. Additionally, as early as E8.5, the most peripheral ventricular cardiomyocytes in the heart of RXRα null mutants show precocious features of differentiation, such as myofibril striation, indicating that RXRα normally plays an early role in the differentiation of these cells. However, the aforementioned cell differentiation defect, which is also exhibited by RARα null mutants, is not sufficient to account for the hypoplasia of the myocardium [65] . The requirement of RXRα for myocardial growth is unlikely to be cell-autonomous. Indeed, breeding of a transgenic mouse line specifically overexpressing an RXRα protein in cardiomyocytes onto an RXRα null genetic background does not prevent the hypoplasia of the ventricular myocardium and fetal lethality associated with the RXRα null genotype, even though the transgene is expressed in the ventricles as early as E10.5 [73] . Recent data suggest that RXRα located in the adjacent epicardium may act on myocardial growth through a paracrine mechanism [74] . In addition to the abnormal histogenesis of the ventricular myocardium, downregulation of genes involved in general metabolism in RXRα null embryos might participate in their death by cardiac failure [75] .
About one-third of the RXRα null mutants lack the conotruncal septum, which normally divides the embryonic heart outflow tract (or conotruncus) into the intracardiac portions of the aorta and pulmonary trunk [24] . Interestingly, deficiencies of this septum represent both a classical VAD defect in rodents and a leading cause of human congenital heart defects, ranging from high interventricular sep-tal defects to double outlet right ventricle (DORV). The agenesis of the conotruncal septum in RXRα null mutants appears secondary to an enhanced rate of cell death in both the mesenchymal cells of the conotruncal ridges and the parietal conotruncal cardiomyocytes, therefore indicating that RXRα is required for the transduction of the RA signal that controls apoptosis in the conotruncal segment of the embryonic heart [44] .
In addition to heart defects, all fetuses lacking RXRα show a characteristic ocular syndrome associating a PHPV, closer eyelid folds, thickened ventral portion of the corneal stroma, ventral rotation of the lens, agenesis of the sclera, and a shorter ventral retina [24] (Table 2) . As similar defects are present in VAD fetuses and in RARβγ double null mutants [8, 35] (Table 2 ), RXRα appears essential to transduce the RA signals required for several ocular morphogenetic processes, notably the formation of the ventral retinal field. Interestingly, this later event critically requires the activity of a specific retinaldehyde dehydrogenase, RALDH3 [76, and our unpublished results].
That all the congenital defects exhibited by RXRα null fetuses are also observed in RAR single or double null mutants provided the first genetic evidence of a convergence between RAR and RXR signaling pathways, and also gave the first clue that RXRα/RAR heterodimers are the functional units that transduce RA signals in vivo (see below).
RXRs CAN BE TRANSCRIPTIONALLY ACTIVE, AND THE AF-1-CONTAINING A/B REGION AND THE AF-2 TRANSCRIPTIONAL ACTIVATION FUNCTION OF RXRa ARE DIFFERENTIALLY INVOLVED IN OCULAR MORPHOGENESIS AND IN MYOCARDIAL GROWTH
Whether RXRs are transcriptionally active within RAR/RXR heterodimers has been a controversial issue in in vitro studies (see Introduction). To determine the roles played by RXRα AF-1 and AF-2 activities in vivo, mouse mutants were engineered that express truncated RXRα proteins lacking either (i) most of the RXRα N-terminal A/B region that includes AF-1 (RXRαaf1 o mutants [77] ), or (ii) the C-terminal 18 amino acid-long sequence of the RXRα protein that includes the core of the activating domain of the activation function 2 (AF-2AD core) (RXRαaf2 o mutants [22] ), or (iii) both AF-1 and AF-2 activities (RXRαaf o mutants; Mascrez et al., unpublished results).
RXRαaf2 o mutant mice occasionally display the hypoplasia of the myocardium and the ocular syndrome characteristic of the RXRα null syndrome, whereas RXRαaf1 o mutants never display RXRα-like developmental defects apart from a small and weakly penetrant PHPV [22, 77] . The low frequency in RXRαaf2 o mutants, and near-absence in RXRαaf1 o mutants, of defects that are fully penetrant in RXRα null mutants could reflect a functional compensation by RXRβ and/or RXRγ (note that RXRβ null, RXRγ null, as well as RXRβγ double null mutants develop normally; see below). This seems, indeed, to be the case for RXRαaf2 o mutants as (i) the frequency of their ocular syndrome increases from less than 15 to 100 % upon further inactivation of RXRβ (which has no effect on its own), and (ii) the frequency of their myocardial defect increases from 5 to about 50 % upon additional inactivation of either the RXRβ gene, or of both the RXRβ and the RXRγ genes, yielding RXRαaf2 o /RXRβ null and RXRαaf2 o /RXRβ null/RXRγ null fetuses, respectively [22] . On the other hand, PHPV is the only defect of the RXRα null syndrome whose frequency is increased in RXRαaf1 o /RXRβ null/RXRγ null mutants, when compared to RXRαaf1 o mutants [77] .
Even though it can be achieved only in an impaired genetic background, the full penetrance of the RXRα null ocular phenotype that is obtained in RXRαaf2 o /RXRβ null mutants (and also in RXRαaf o mutants; [22] and unpublished results), supports the view that the RXRα AF-2 activity (and thus possibly 9-cis RA) is indispensible for ocular morphogenesis. In contrast, involution of the primary vitreous body, the developmental process which is likely to require the highest concentration of RA-liganded receptor (as it is the event the most sensitive to VAD) [8] , requires the additional integrity of the RXRα A/B domain, while in a wild-type this latter domain is dispensible for the other RA-dependent ocular M. MARK AND P. CHAMBON morphogenesis event. These interpretations are supported by the observations that RXRα null-like ocular abnormalities: (i) affect 100 % of RXRαaf1 o /RAR(β null or γ null) double mutants, whereas (with the exception of the PHPV) they are all absent in the corresponding single null mutants and (ii) are rare in RXRαaf2 o mutants, but fully penetrant in RXRαaf2 o mutants, which additionally lack the AF-1 containing RXRα A/B region. Altogether, these data strongly support the view that the activation functions of RXRα are required for normal eye development, and also that, due to functional redundancy, the role played by RARα AF-1 and AF-2 can be revealed only in certain impaired genetic backgrounds (or RA insufficiency conditions).
On the other hand, the rare occurrence of hypoplasia of the myocardium in RXRαaf2 o and RXRαaf1 o /RXRβ null/RXRγ null fetuses, and only in half of the RXRαaf2 o /RXRβ null/RXRγ null fetuses, suggests that the transcriptional activity of RXRα is necessary for myocardial growth only in "unfavorable" genetic backgrounds. Along the same lines, we recently found that the vast majority (80 %) of RXRαaf o fetuses display a normal heart histology (our unpublished results), thereby demonstrating that a transcriptionally "silent" RXRα can efficiently promote myocardial growth and ruling out the requirement for an RXR ligand in this developmental process.
Interestingly, RXRαaf2 o and RXRαaf o mutants die at birth even though only few of them display a hypoplasia of the myocardium. Thus, both their lethality and severe growth retardation may be at least in part secondary to metabolic problems arising from placental defects (see below).
SPECIFIC FUNCTION OF THE RXRa AF-1 DOMAIN-CONTAINING A/B REGION IN INVOLUTION OF INTERDIGITAL MESENCHYME
AF-2 appears to be more important than AF-1 for the function of RXR during embryonic development: RXRαaf2 o /RXRβ null/RXRγ null fetuses all die in utero and display a large array of congenital defects, whereas RXRαaf1 o /RXRβ null/RXRγ null mutants are often viable and display few congenital defects. Moreover, AF-2 but not AF-1 of RXRα is crucial for transcription of a RA responsive lacZ reporter transgene in the mouse [22, 77] . Note, however, that all RXRαaf1 o /RAR (α, β, or γ) compound mutants die in utero and exhibit a large array of malformations that nearly recapitulate the full spectrum of the fetal VAD syndrome, indicating that RXR AF-1 could nevertheless be instrumental to the transcriptional activity of RAR/RXR heterodimers, particularly under conditions of limiting concentrations of RA and/or RA receptors [77] . In this respect, it is noteworthy that RXRαaf2 o /RXRβ double mutants die in utero at a late fetal stage (E14.5 to birth), whereas RXRαaf o /RXRβ mutants, that additionally lack AF-1, die at midgestation (E10.5) (our unpublished results). Interestingly, the RXRα A/B region, which supports the AF-1 activity, has also a unique role in the RA-dependent disappearance of the interdigital mesenchyme.
The first evidence implicating RA in the involution of the interdigital mesenchyme was provided by whole limb cultured in a RA-deprived medium [78] . Subsequently, it was shown that mice lacking both alleles of either the RARα or the RARγ genes, as well as mice heterozygous for the RXRα null mutation occasionally exhibit mild forms of interdigital webbing (soft tissue syndactyly) ( [24, 28, 35, 38] ; Table 1) . Surprisingly, this defect was absent in RARβ null mutants, even though RARβ is strongly and specifically expressed in interdigital necrotic zones (INZs) ( [35] ; and references therein). However, interdigital webbing is severe and completely penetrant upon disruption of one (or both) allele(s) of the RARβ gene in a RARγ null genetic background [35] . The persistence of the fetal interdigital mesenchyme is caused by marked decrease in programmed cell death, as well as by an increase of cell proliferation in the mutant INZs [64] . As RARβ and RARγ are not co-expressed in the INZs, involution of the interdigital mesenchyme must involve paracrine interactions between the interdigital mesenchyme (the site of RARβ expression), and either the cartilaginous blastema of the digits or the surface epidermis, which both express RARγ. RARβ/RARγ (RARβγ) compound mutants also display a specific downregulation of tissue transglutaminase (tTG) promoter activity and of stromelysinments in the promoter regions of both tTG and stromelysin 3 genes suggests that RA might promote cell death in the INZs through a direct increase of tTG expression, and could also contributes to the tissue remodeling, which accompanies cell death through an increase of stromelysin 3 expression [64] . It has also been shown that the expression of the anti-death gene BAG-1, which is normally downregulated upon initiation of interdigital apoptosis, remains unaltered in the limbs of RARβγ double null mutants [79] .
The RXRα A/B region is indispensable for the function of RXRα/RARβ and/or RXRα/RARγ heterodimers in the involution of the interdigital mesenchyme, as the majority of RXRαaf1 o mutants and all RXRαaf1 o /RXRβ null/RXRγ null mutants display soft tissue syndactyly [77] . Moreover, this function selectively requires the RXRα A/B region, as RXRαaf2 o and RXRαaf2 o /RXRβ null/RXRγ null mutants never display this defect [22] . Interestingly, phosphorylation of RXRα at a specific serine residue located in the A domain is necessary for the antiproliferative response of F9 teratocarcinoma cells to RA [26, 80] . Therefore, within RXRα/RAR (β and γ) heterodimers, phosphorylation of the RXRα A domain may play an important function in the cascade of molecular events that, in vivo, leads to the normal disappearance of the interdigital mesenchyme.
RETINOIC ACID SIGNALS ARE TRANSDUCED DURING DEVELOPMENT BY SPECIFIC
RXRa/RAR(a, b, OR c) HETERODIMERS
Compound mutants in which a null mutation of a given RAR isotype (α, β, or γ) is associated either with (i) a RXRα null mutation, (ii) a RXRαaf1 o mutation, or (iii) a RXRαaf2 o mutation, altogether recapitulate the abnormalities exhibited by RAR double null mutants [22, 24, 47, 77] (Table 4 , and see examples below). This synergism between RAR and RXRα loss-of-function mutations support the conclusion that RXRα/RAR heterodimers are the functional units that transduce RA signals during embryonic development. Moreover, RXRα is the functionally most important RXR during development, as the development of RXRβ/RXRγ double null mutants appears to be normal [81] . This last conclusion is further supported by a lack of synergism during development between RAR (either α, β, or γ) and RXRβ or RXRγ inactivations [47] .
The analysis of the various RXRα/RAR compound mutants led to the identification of the heterodimers, which, in a given developmental process, are preferentially involved in transducing RA signals. For instance, hypoplasia of the myocardium is never seen in RAR(α, β, and γ) single null mutants nor in RXRαaf1 o single mutants, while it is found in less than 5 % of RXRαaf2 o single mutants. On the other hand, 45 % of RXRαaf1 o /RARα null mutants (but none of the RXRαaf1 o /RARβ null or RARγ null mutants) and 80 % of RXRαaf2 o /RARα null mutants (but only 20 % of RXRαaf2 o /RARβ null or RARγ null mutants) display this defect [22, 77] . Thus, these genetic analyses indicate that RXRα acts on myocardial growth preferentially in the form of heterodimers with RARα.
Similarly, several lines of evidence indicate that, although all three RARs are expressed in developing ocular structures [82] , RXRα acts on eye morphogenesis in the form of heterodimers with either RARβ or RARγ, but not with RARα. Firstly, there is a strong synergism between RXRα and RARβ or RARγ inactivations, which is manifested by a marked increase in the severity of the RXRα null ocular defects in RXRα/RARβ and RXRα/RARγ double null fetuses (Table 4) [47] . Secondly, there is also a strong synergism for the generation of RXRα null-like ocular defects between RARβ or RARγ inactivations and ablations of either RXRα AF-1 or RXRα AF-2. Indeed, apart from the PHPV, the RXRα null ocular syndrome is never present in RAR(α, β, and γ) single null mutants nor in RXRαaf1 o single mutants, and is found in only a minority (less than 15 %) of RXRαaf2 o single mutants. On the other hand, this ocular syndrome is observed in 100 % of RXRαaf1 o /RAR(β null or γ null) and RXRαaf2 o /RAR(β null or γ null) double mutants, whereas it is absent in RXRαaf1 o /RARα null mutants, as well as in RXRαaf2 o /RARα null mutants [22, 77] . These results indicate that RXRα/RARβ and RXRα/RARγ heterodimers are instrumental in ocular morphogenesis. 
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SELECTIVE FUNCTIONS OF RXRb AND RXRc IN THE CONTROL OF FERTILITY, METABOLIC PROCESSES, AND BEHAVIOR
RXRβ null mutant males are sterile due to abnormal spermatid maturation and release, leading to a severe number reduction, decreased mobility and high percentage of abnormalities of spermatozoa. As the RXRβ protein is only detectable in Sertoli cells, a dysfunction of these cells most probably accounts for the spermiogenetic defects in RXRβ null mutants. Moreover, large lipid droplets accumulate in the cytoplasm of RXRβ null Sertoli cells, suggesting functional interactions between RXRβ and nuclear receptor signaling pathways controlling lipid metabolism [83] . Interestingly, males lacking only the AF-2 activity of RXRβ (RXRβaf2 o ) are fertile, but display a Sertoli cell-restricted lipid metabolic defect identical to that of the RXRβ null mutant males (our unpublished results). Altogether, these data demonstrate that within the Sertoli cell, RXRβ exert independent functions in spermiogenesis and lipid metabolism and, as lipid accumulations in tissues are never observed under VAD conditions, they also provide the first in vivo evidence that the AF-2 activation function of an RXR can be important for the transcriptional activity of heterodimers other than RXR/RAR. RXRγ null mutants are fertile and morphologically indistinguishable from wild-type littermates. They exhibit a mild thyroid hormone resistance and an increased metabolic rate [84] , and also show defects in cognitive functions [46] . Moreover, the recent observation that growth plate development is more severely impaired in RXRγ/VDR double null mutants than in VDR single null mutants, has sug-gested that RXRγ/VDR heterodimers may be involved in the differentiation of hypertrophic chondrocytes [85] .
Similarly to RARβ, RXRβ and RXRγ are expressed at high levels in the striatum, the main dopaminergic signaling organ controlling coordination of movements. Abnormal locomotor behaviors in RXRβ/RARβ, RXRγ/RARβ, and RXRβ/RXRγ double null mutant mice, and to a lesser extent in single null mutants of these receptors, are correlated with dysfunction of the mesolimbic dopaminergic signaling pathway. Indeed, expression of dopamine receptors types 1 and 2 (DR1 and DR2) in the ventromedial regions of the striatum of these double mutants are significantly reduced, and their response to cocaine, a modulator of dopamine signaling, is blunted [45] . The expression of D2R in the striatum of the mutant animals may be altered at the transcriptional level, as a functional RA response element has been characterized in the promoter of the corresponding gene [86] . That RXRβ/RARβ and RXRγ/RARβ heterodimers mediate retinoid signals required for the function of the mesolimbic dopaminergic system suggests that RA signaling defects may contribute to pathologies such as Parkinson's disease and schizophrenia.
PLACENTATION FIRST REQUIRES A TRANSCRIPTIONALLY "SILENT" RXR, THEN AN ACTIVE RXRa
Embryos carrying null mutations of both RXRα and RXRβ (RXRαβ) double null mutants display a wide range of abnormalities resembling those of embryos carrying blocks in RA signaling, e.g., RALDH2 null and RARα/RARγ double null mutants (see above). However, they exhibit a unique lethality that occurs at midgestation and appears to be caused by a labyrinthine agenesis, i.e., the lack of formation of the labyrinthine zone of the chorioallantoic placenta [87] . In the normal placenta, this zone represents the main site of exchanges between mother and embryo. Labyrinthine agenesis is never associated with RAR single or double null mutant embryos, but a similar, although less severe abnormality (i.e., a labyrinthine hypoplasia) is seen in embryos lacking either PPARβ or PPARγ [88, 89] . At later, fetal stages of gestation, the placenta of RXRα single null mutant displays a thickening of the labyrinthine trabeculae, which are interposed between maternal blood sinuses and fetal capillaries, and represent the placental barrier across which nutrient and gas exchanges between the maternal and fetal blood occur [90] .
Altogether, these results indicate that RXRs are involved in placentation at two distinct steps. At E8.5, RXRα and/or RXRβ are required for the initial formation of the placental labyrinthine trabeculae from the chorionic plate. Between E14.5 and the term of pregnancy (E19.0), RXRα is required for the proper differentiation of the trophoblast cells forming the labyrinthine trabeculae. The early RXR-dependent step of placentation (formation of the labyrinth), does not involve RXR/RAR heterodimers, and as RXRα/RAR (α, β, or γ) double null fetuses do not die earlier than RXRα single null fetuses, this probably also applies to the later step [47] . Moreover, the early step is taking place normally in RXRαaf o /RXRβ null placentas, as well as in placentas lacking all RXR AF-1 activities (RXRαaf1 o /RXRβ null/RXRγ null placentas) or all AF-2 activities (RXRαaf2 o /RXRβ null/RXRγ null placentas) ( [77] , and unpublished results). Therefore, the heterodimers involved in the initial stages of labyrinthine formation, presumably RXR(α and/or β)/PPAR(β and/or γ) heterodimers (see above), do not require a transcriptionally active RXR. In contrast, as RXRαaf2 o placentas reproduce with a complete penetrance the histological defects of RXRα null placentas, the later RXRα-dependent step of placentation (differentiation of the labyrinthine trophoblast), depends critically on the AF-2 ligand binding-dependent transactivation function of RXRα [77] .
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COMBINING GENETIC AND PHARMACOLOGICAL APPROACHES PROVIDE CLUES ON RAR-DEPENDENT CELLULAR MECHANISMS OPERATING DURING EMBRYOGENESIS
The endoderm of branchial arches is a major target of RA action mediated by RARα and/or RARβ
Mutants carrying targeted inactivations of both the RARα and RARβ genes (RARαβ mutants), analyzed at fetal stages of gestation, display the complete set of defects generated in the chick by surgical ablation of large portions of the post-otic neural crest, namely thymus and parathyroid gland ageneses or ectopias, aberrant pattern of the great cephalic arteries, absence of the pulmonary arteries, and aorticopulmonary septum [35,37,50, and refs. therein] . These defects are also present in the DiGeorge syndrome, which is an archetype of human neurocristopathy, i.e., "a condition arising from aberrations of the early migration, growth, and differentiation of neural crest cells (NCC)" [91] . These and other observations led to the proposal that cranial NCC fated to give rise to mesenchymal derivatives (i.e., the mesectodermal cells) are major targets of RA action [37] . Unexpectedly, RARαβ double null mutants analyzed at embryonic stages of gestation do not show NCC alterations, but their caudal branchial arches (BAs) are very small [60] . BAs are transient bulges of the embryonic head and neck, partially filled with NCC and separated from one another by evaginations of the endoderm, the pharyngeal pouches. Caudal BA and pouches give rise to the adult organs affected in the aforementioned NCC ablation experiments. As BA defects of RARαβ embryos are less severe than those of RALDH2 null embryos, which are devoid of RA [52] , they do not reflect a complete block in RA signal transduction. To analyze NCC migration and formation of BA and pharyngeal pouches in a situation where the degree of the block in RA signal transduction could be modulated and its timing precisely controlled, a culture system was designed in which wild-type embryos are exposed to a panRAR antagonist, BMS493 [57] .
Treatment with the panRAR antagonist induces a complete lack of caudal BA and pharyngeal pouches, and disturbs the paths of post-otic NCC migration, however, without affecting the amount of NCC. Moreover, and most interestingly, this treatment inhibits caudal BA development only during a narrow window of time which does not correspond to the period of post-otic NCC migration. Both the nature and time of appearance of the defects in panRAR antagonist-treated embryos indicate that, contrary to what was expected from the set of abnormalities displayed by RARαβ double null fetuses, migrating NCC destined to the caudal BA do not represent primary targets of RA action. On the other hand, the antagonist-induced alterations in endodermal expression of "patterning" genes (e.g., Hoxa1, Hoxb1, Pax1, Pax9) and of genes encoding signal peptides (Fgf3 and Fgf8), indicate that RA signaling (i) is required to specify the pharyngeal endoderm, and (ii) may provide a permissive environment for NCC migration through endodermal secretion of specific paracrine factors [57] . These data also raise the possibility that genes deleted in the human DiGeorge syndrome are actually expressed in the endoderm under the control of RA as early as the fourth week of gestation.
RARs act on top of a genetic cascade controlling hindbrain segmentation
The hindbrain of vertebrate embryos is transiently divided into segments (rhombomeres), of which seven (R1 to R7) are visible in mammals. Although early and transient, hindbrain segmentation is instrumental in organizing adult structures, such as cranial nerves. The coordinated expression of several transcriptional regulators is required to pattern the embryonic hindbrain from an initially unsegmented "naïve" neural plate. These transcriptional regulators: (i) control the segmentation process, through which the cells located within the nascent rhombomeres acquire distinct adhesive properties preventing them to mix together, and/or (ii) impart segmental identity, i.e., the acquisition by these cells for specific molecular addresses that will determine their definitive fates. These transregulators also commonly serve as molecular markers of specific rhombomeres in in situ hybridization assays [58, and refs. therein] The hindbrain of RARα/RARγ double null mutant (RARαγ) embryos shows a posterior expansion of R3 and R4 markers, but fails to express kreisler, a specific marker of R5 and R6. In contrast, the neurectodermal territory corresponding to R5 and R6 is markedly enlarged in RARα/RARβ double null mutant (RARαβ) embryos. Treating E7.0 wild-type embryos with the panRAR antagonist BMS493 produces a phenocopy of the RARαγ hindbrain abnormal phenotype, whereas this treatment started at E8.0 results in a RARαβ-like phenotype. Thus, distinct hindbrain phenotypes in RARαβ and RARαγ null embryos are related to different time windows of RA action: at E7.5 (the time at which embryonic RA synthesis begins), RARγ (and RARα) transduce a signal required to specify the R5/R6 territory; at E8.0, a RARβ-(and RARα)-mediated local increase in RA signaling in the posterior portion of the hindbrain controls the position of the R6 caudal boundary, thus allowing the next caudal rhombomere, R7, to be specified.
That the expression domains of several important hindbrain patterning genes are altered in RARαβ and RARαγ mutant embryos [58] provides evidence that RA acts on top of the genetic hierarchy controlling hindbrain patterning. Moreover, generation of a graded embryonic block in RA signal transduction through varying the concentrations of the panRAR antagonist in the culture, demonstrates that individual rhombomeres are specified by distinct thresholds of RA signaling, and support the view that RA acts as a posteriorizing signal for the patterning of the embryonic hindbrain [58,92, and refs. therein] . Thresholds levels of RA signaling could be set up through modulations of RAR levels, and/or of RA-synthesizing and metabolizing enzyme expression domains [56,93-96, and refs. therein] .
RA signals mediated by RXRα/RARα and RXRα/RARβ heterodimers have opposite effects on lung-branching morphogenesis
The discovery that VAD rat fetuses often display bilateral lung hypoplasia as well as oesophagotracheal septum agenesis provided the first indication that RA signaling is important for the development of the respiratory system [8] . VAD-related lung and tracheal malformations are absent in RAR (α, β, and γ) single null mutants, but are seen in all RARαβ double null mutants [35, 50] . Although RARβ can apparently efficiently compensate for the loss of RARα in RARα single null mutants, the functions of these two RARs in prenatal lung growth are not equivalent. Indeed, RARα/RXRα double null mutants constantly display severe lung hypoplasia and oesophagotracheal septum agenesis, whereas RXRα/RARβ double null mutants never show these defects. This observation confirms that functional compensation within the RAR family is much less efficient when RXRα, the main heterodimeric partner of RARs during embryonic development, is absent [see ref . 47 ]. As mentioned above, the genetic dissection of the retinoid signaling pathway strongly suggests that the functional units involved in the primary lung bud and trachea formation are RXRα/RARα heterodimers [47] . Thus, formation of the primary lung buds provides another example of developmental processes that seemingly involve specific heterodimers.
To investigate the role of RA signaling pathways during primary lung bud formation and subsequently during branching morphogenesis, wild-type embryos or lung explants were cultured in the presence of RA and of the specific panRAR antagonist, BMS493 [69] . PanRAR antagonist treatment of embryos at E8.0, prior to the first appearance of the primary lung buds, inhibits their outgrowth and causes a failure of oesophagotracheal fold formation, indicating that (i) a RA signaling is required for the formation of the primary lung buds from the primitive foregut and (ii) the severe lung and tracheal defects observed at fetal stages of gestation in RARαβ and RXRα/RARα double null mutant mice, as well as in VAD rats, are determined prior or at the onset of lung development [69, and refs. therein] .
PanRAR antagonist treatments of explants collected at a later stage of lung-branching morphogenesis, increase the number of distal buds, the sites of lung branching, whereas RA administered during this period has an inverse effect [69, 97] . This RA-induced inhibition of lung branching is apparently mediated by RARβ. RARβ transcripts are strictly confined to the morphogenetically stable proximal bronchi during in vivo lung development [44] . However, the branching inhibition induced by RA correlates with an ectopic expression of RARβ in distal buds, whereas stimulation of lung branching caused by the panRAR antagonist correlates with a decrease of RARβ expression in proximal bronchi. Additionally, RA treatments that decrease the number of distal buds in wild-type explants do not affect M. MARK AND P. CHAMBON explants from RARβ null mutants. Collectively, these findings support the view that activation of RARβ by RA favors morphogenetic stabilization of the developing pulmonary tree [69] . Such a negative control of embryonic lung growth by a RARβ signaling pathway might be disturbed in the congenital cystic adenomatoid malformation, a human pathology characterized by an overgrowth of bronchial tissue at the expenses of the alveolar tissue.
Interestingly, RARβ-transduced RA signals, in addition to negatively regulate lung-branching morphogenesis in utero, also negatively regulate, after birth, the process of alveolar septation [98, 99] . Suppressing perinatal RARβ signaling by selective antagonists may thus offer a novel mean of preventing, or curing, failed septation in prematurely born children suffering from bronchopulmonary dysplasia. In contrast, RXRα/RARγ heterodimers appear to be positively involved in alveolar morphogenesis during the perinatal period [100] , while RARα may regulate alveolar formation after the perinatal period [99, 101] .
COMBINING GENETIC AND PHARMACOLOGICAL APPROACHES PROVIDE CLUES ON RAR AND RXRa-MEDIATED TERATOGENIC EFFECTS
RA is a potent teratogen which, at pharmacological concentrations, can induce congenital defects in all vertebrate species as well as in certain invertebrates [102] [103] [104] . RA treatments of animals overexpressing, or carrying null mutations of retinoid receptors, have provided evidence that teratogenic effects of retinoids are receptor-mediated. For instance, it was shown that RARγ null embryos are resistant to RA-induced caudal truncations, whereas RXRα null embryos are resistant to RA-induced limb defects and cleft palate [38, [105] [106] [107] .
In humans, oral intake of Accutane (13-cis RA) during gastrulation and early organogenesis (gestational weeks 2-5) results in a spectrum of congenital malformations collectively referred to as the retinoic acid embryopathy (RAE) [108] . It has been assumed that the branchial arch (BA) defects observed in RA-exposed embryos at the equivalent of E8.0 and E9.0 in the mouse, can account for alterations displayed in newborns, and that neural crest is the primary target tissue of RA-induced teratogenesis in the BA region of the embryo [109, 110] .
Fusion and hypoplasia of the first two BA, a hallmark of RAE, is generated in E8.0 cultured mouse embryos upon treatment with BMS453, a synthetic compound exhibiting RARβ agonistic properties in transfected cells [111] . In contrast, no BA defects are observed following treatment with synthetic retinoids exhibiting RARα or RARγ agonistic properties. These BMS453-induced BA defects are enhanced in the presence of a panRXR agonist, that is not teratogenic on its own, and they are accompanied by ectopic expression of RARβ and of several other direct RA target genes in the morphologically altered region. On the other hand, BA defects and ectopic expression of RA target genes cannot be induced in RARβ null embryos upon BMS453 treatment. Altogether, these data indicate that craniofacial abnormalities characteristic of RAE are mediated through ectopic activation of RXR/RARβ heterodimers, in which the ligand-dependent activity of RXR is subordinated to that of RARβ.
RAE apparently meets the criteria for a neurocristopathy [91; and see above]. However, NCC do not appear to be primary targets of RA-induced teratogenicity as: (i) retinoid-induced fusion of the first and second BA occurs without alterations of NCC migration or apoptosis [110] and (ii) contrary to other embryonic tissues, NCC do not express a RA-responsive transgene upon treatment with BMS453. In contrast, treatment with BMS453 triggers a RARβ-dependent RA signaling in the endoderm lining the first two BA, manifested by rostral shifts of the expression domains of RA-responsive patterning genes, such as Hoxa1 and Hoxb1. Hox gene expression is thought to play an important role in antero-posterior regionalization of the pharyngeal endoderm [57; and refs. therein], while pharyngeal endoderm plays a seminal role in the formation of BA, through imparting patterning information to NCC [112] . Thus, the current data support the view that many RAE defects can result from an abnormal function of the pharyngeal endoderm [111, 113] .
CONCLUSIONS AND PERSPECTIVES
We have reviewed here the results of phenotypic analyses of single and compound germline mutants lacking RAR and RXR isotypes and/or isoforms, and of mutants lacking the RXRα transactivation functions. These analyses have provided the first compelling evidence that RA is actually the active metabolite of vitamin A during embryonic development, which was subsequently confirmed by the demonstration that RA synthesized by the retinal deydrogenases 2 and 3 (RALDH2 and RALDH3) acts as an indispensable developmental hormone [52] [53] [54] 56, 114 , and our unpublished results]. These genetic studies have also led to equally important conclusions concerning the physiological functions played by the multiple RAR and RXR receptors in vivo, notably during early embryogenesis and organogenesis, but also postnatally. Moreover, they strongly supports the conclusion that the molecular mechanisms underlying the transduction of the RA signal by retinoid receptors, as they have been deduced from in vitro studies in acellular and cellular systems (see Introduction), are also instrumental in RA signaling under truly physiological conditions, i.e., at the organismal level.
Several lines of evidence lead to the conclusion that RXR/RAR, notably RXRα/RAR heterodimers are the main functional units that transduce RA signals during development, and that specific RXR/RAR pairs are involved in given developmental processes. This strongly supports the initial proposal [14] that the highly pleiotropic effects of RA reflect sophisticated combinatorial mechanisms through which multiple RXR/RAR heterodimers differentially transduce retinoid signals to selectively control the expression of numerous sets of RA target genes controlling the shaping and axial patterning of the early embryo, and subsequently multiple aspects of organogenesis.
The mouse genetic studies also demonstrate that within RXR/RAR heterodimers, the RXR partner can be either transcriptionally active (and thus synergistically acting with its RAR partners) or inactive, depending on the developmental event under consideration. However, as previously demonstrated in vitro (see Introduction), it appears that the transcriptional activity of the RXR partner is subordinated to ligand binding to the RAR partner [111, 115] . Moreover, when RXRα is transcriptionally active, either one (AF-1 or AF-2) or both activation functions can be instrumental, and their activity also depends on the nature of the RA-controlled event. The frequent requirement of RXRα AF-2, whose transcriptional activity is known to be dependent on 9-cis RA from studies in vitro, strongly suggests that this retinoid or a similar ligand could be instrumental in transactivation by RXR heterodimers in vivo (for further discussions, see ref. [22] ). Note that, as the role of RXRα AF-1 has been inferred from deletion of the whole A/B region [77] , and as phosphorylation of the RXRα A region has been shown to be required for AF-1 activity in studies in vitro [80] , it will be interesting to genetically investigate the function of this phosphorylation in the mouse.
The genetic study of the physiological roles of RAR and RXR has revealed an extensive functional redundancy within the members of each family (RARs or RXRs), although in all cases each of these members appears to individually exert at least one specific physiological function. Even though this functional redundancy is not surprising, as the members of each family share a common ancestor, it raises the question as to whether it is physiologically relevant or artefactually generated when a given RAR or RXR is knocked out, as it has been shown to be the case in cellular studies in vitro [26, 116] . It is not unlikely that, in most instances, the functional redundancy does not exist under wild-type conditions. In fact, redundancy is frequent within the RAR or the RXR families, i.e., a given defect is very frequently or exclusively seen in either RAR/RAR or RXRα/RXR double null mutants, while it is weakly penetrant or absent in the corresponding single null mutants). In striking contrast, redundancy is less frequent in the case of the RXRα/RAR heterodimer knock-out which generates this defect in a fully penetrant manner. As discussed extensively elsewhere [22, 47, 77] , assuming that RXRα/RAR heterodimers are indeed the functional transducing units, the easiest way to interpret these observations is to postulate that redundancy can occur when only one of the two partners of the physiological heterodimer is ablated. In other words, the activity of a given heterodimer selectively involved in the control of a given event may still be above a physiological threshold level when either one of the two partners M. MARK AND P. CHAMBON (RXR or RAR) is ablated, but not when both are missing. Therefore, the selective involvement of a given RAR or RXR could be revealed only under conditions where the threshold level is not reached, which would also account for the observations that single isoform knock-outs are often phenotypically normal, and that the role of the RXRα AF-1 or AF-2 functions cannot be fully revealed unless the activity of the heterodimer is altered by the additional mutation of the RAR partner, or by knock-out of one or both of the potentially redundant RXR isotypes. Thus, any conditions (e.g., a decrease availability of intracellular RA) that would lower the activity of RXR/RAR heterodimers and bring it close to physiological threshold levels, may reduce or abrogate functional redundancy. As the actual intracellular concentration of RA could be more limiting in the wild than in animal facilities, functional redundancy may be less prominent in natural environments. In this respect, it is worth mentioning that, even though phosphorylation of either RAR AF-1 or AF-2 domains can be required for RA-induced differentiation of F9 EC cells in vitro [26] , mouse mutants bearing mutations in the phosphorylated amino acid residues are apparently normal (our unpublished results). Therefore, it will be worth investigating whether the function of these phosphorylations can be revealed under conditions of limited RA supply. Similar conditions could also reveal selective functions of the various RAR and RXR isoforms.
Genetic analysis of RAR and RXR functions have also demonstrated that the teratogenic effects resulting from administration of exogenous RA to embryos do not reflect a physiological role of endogenous RA in the corresponding developmental processes. Indeed, in two instances in which an involvement of a given RAR or RXR in the mediation of a teratogenic event was demonstrated, the same receptor was clearly not required for the development of the corresponding structure during embryogenesis. This is the case for the RA excess-induced lumbosacral truncation that is mediated by RARγ [38] and the RA excess-induced limb truncations that do not occur in RXRα mutants [106] .
Clearly, the generation of RAR and RXR germline mutations, combined with pharmacological approaches to block the RA signaling pathway, have provided many valuable insights on the developmental functions of RA receptors. However, this strategy has intrinsic limitations that are mostly due to the introduction of the mutation in the germline. First, the effect of a germline mutation may be functionally compensated during development, thus precluding the appearance of a defect in the adult animal. On the other hand, the mutation can be lethal in utero or postnatally, thus preventing analysis of the functions of the gene at later developmental or postnatal stages. This is the case for RXRα knockout. Along the same lines, germline mutations can arrest the development of a given organ at an early stage, thus preventing further analysis of the gene functions at later stages of organogenesis. For instance, the function of RARβ in lung-branching morphogenesis is not revealed in RARβ single mutants, and therefore remains cryptic in RARαβ double null mutants in which a very early step of embryonic lung formation is impaired. Moreover, introducing mutations in the germline often makes it very difficult to distinguish cell-autonomous from non-cell-autonomous functions of a gene belonging to a family involved in highly pleiotropic signaling pathways. Thus, in many instances, these limitations of germline mutations prevent the determination of the function of a given gene product in a defined tissue at a given time of the animal life. This is obviously the case for RARs and RXRs.
To overcome these limitations, strategies for targeted spatio-temporally controlled somatic mutagenesis of RARs and RXRs in the mouse have been designed, which are based on cell-type-specific expression and inducible activity of the bacteriophage P1 Cre recombinase. To that end, conditional tamoxifen-inducible Cre recombinases (called Cre-ER T and Cre-ER T2 ) have been generated by fusing Cre with a mutated ligand-binding domain of the estrogen receptor ERα which binds tamoxifen, but not estrogens [117, 118] . Selective ablation of the RXRα and RARγ genes in keratinocytes indicate that RXRα has key roles in hair cycling, most probably through RXR/VDR heterodimers, as well as in homeostasis of proliferation/differentiation of epidermal keratinocytes and of the skin immune system though non-RXRα/RAR(α, β, or γ) heterodimers [41, 119, 120] . The same approach applied to adipocytes and hepatocytes has demonstrated that RXRα is involved both in preadipocyte differentiation, adipogenesis, and lipolysis, probably in the form of RXRα/PPARγ heterodimers [121] , and plays important cell-autonomous functions in mechanisms that control the lifespan of hepatocytes and are in-volved in liver regeneration [122] . These examples show that the combined use of transgenic mouse lines expressing tamoxifen-inducible chimeric Cre recombinases in specific cell-types and of mouse lines harboring "floxed" receptor genes will provide invaluable mouse models to further elucidate the in vivo functions of retinoid receptors.
